First, we plotted the Kaplan-Meier models using the survival statistics from glioma samples from the TCGA and CGGA sets (Figure 2A and B), and those patients with highly expressed PLVAP exhibited significantly shorter overall survival (OS) time (P < 0.0001). This evidence concerns the gene PLVAP and central nervous system cancer.